WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) was up 42.4% during mid-day trading on Thursday . The stock traded as high as $13.1350 and last traded at $18.8850. Approximately 465 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 948 shares. The stock had previously closed at $13.2623.
WisdomTree BioRevolution Fund Trading Up 39.9%
The company has a market capitalization of $2.78 million, a price-to-earnings ratio of 17.03 and a beta of 1.01. The firm has a 50-day moving average price of $17.45 and a 200-day moving average price of $16.06.
Institutional Inflows and Outflows
An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC increased its holdings in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,864 shares of the company’s stock after purchasing an additional 5,306 shares during the period. Jane Street Group LLC owned approximately 11.24% of WisdomTree BioRevolution Fund worth $231,000 at the end of the most recent quarter.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
See Also
- Five stocks we like better than WisdomTree BioRevolution Fund
- A U.S. “birthright” claim worth trillions – activated quietly
- Trump’s AI Secret: 100X Faster Than Nvidia
- Buy This Stock at 9:30 AM on MONDAY!
- HUGE gold prediction
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
